首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Diagnostic Approach in Autosomal Dominant Polycystic Kidney Disease
【24h】

Diagnostic Approach in Autosomal Dominant Polycystic Kidney Disease

机译:常染色体显性多囊肾的诊断方法

获取原文
获取外文期刊封面目录资料

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is the most common Mendelian disorder of the kidney and affects all racial groups worldwide. It is characterized by focal development of renal and extrarenal cysts in an age-dependent manner. Typically, only a few renal cysts are detected in most affected individuals before 30 yr of age. However, by the fifth decade of life, hundreds to thousands of renal cysts will be found in the majority of patients. ADPKD is genetically heterogeneous. Mutations of two genes, PKD1 and PKD2, account for approximately 85 and 15% of cases, respectively. Although the clinical manifestations of these two genotypes overlap completely, patients with PKD1 have much more severe renal disease compared with those with PKD2, as evidenced by their ESRD occurring approximately 15 yr earlier. Renal ultrasonography commonly is used for the assessment of ADPKD, and age-dependent ultrasound diagnostic criteria with high sensitivity and specificity have been established for individuals who are born with 50% risk for PKD1. Although these diagnostic criteria are used widely for genetic counseling and for the evaluation of at-risk individuals as living-related kidney donors to their affected relatives, their application to individuals who are at risk for PKD2 or have undefined genotype needs to be refined further. Molecular genetic testing is available for ADPKD and may be useful for evaluation of at-risk individuals with equivocal imaging results, younger at-risk individuals as a living-related kidney donor, and individuals with atypical or de novo renal cystic disease.
机译:常染色体显性遗传性多囊肾疾病(ADPKD)是最常见的孟德尔肾脏疾病,并影响全球所有种族。它的特征是肾脏和肾外囊肿的局灶性发展以年龄依赖性。通常,在30岁之前,在大多数受影响的个体中仅检测到少数肾囊肿。但是,到生命的第五个十年,大多数患者将发现数百至数千个肾囊肿。 ADPKD在遗传上是异质的。两种基因PKD1和PKD2的突变分别占病例的约85%和15%。尽管这两种基因型的临床表现完全重叠,但是与PKD2相比,PKD1患者的肾脏疾病严重得多,其ESRD发生在大约15年之前。通常使用肾脏超声检查来评估ADPKD,并且已经为出生时具有PKD1风险50%的个体建立了具有高灵敏度和特异性的年龄依赖性超声诊断标准。尽管这些诊断标准已广泛用于遗传咨询和评估作为患病亲属的与生命相关的肾脏供体的高危个体,但它们在有PKD2风险或基因型不确定的个体中的应用仍需进一步完善。分子遗传学测试可用于ADPKD,可能对评估影像学结果不清楚的高危人群,作为与生命有关的肾脏供体的年轻高危人群以及非典型或新生肾囊性疾病的个体有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号